May 20, 2025
Recently Charles Joynson, WaveData MD, ran a pricing analysis on Acetazolamide Tabs 250mg 112 and found that Pharmacies and Dispensing Doctors had been losing £18.00 each time they dispensed this product in the three months to end March. Today we thought we’d look at...
Feb 6, 2025
This suspension is one that has been hovering on the edge of unprofitability for a long time and has seen more concessions granted (32) in 2023 – 2024 that any other generic. Between Nov 2017 and Dec 2019 market prices averaged close to or below £4.00. This...
Jan 6, 2025
This product has seen its market price decay from around £13.00 in 2017 – 2020 to a low of £4.29 in September 2024. This may have pushed this combined product, complicated to make due to its combined and device characteristics, into unprofitability as it has...
Nov 15, 2024
With the number of concessions granted by DHSC in October at just 106, the lowest number since May 2022, we wondered if this was a signal of a reduction in the number of shortages or if it was just a blip? To try and understand this issue we needed to get some way of...
Sep 20, 2024
Charles Joynson, WaveData MD, has conducted some indepth analysis to try to identify early warning signs of generic shortages. Here’s the third and final instalment In the first part of this series we looked at Losartan Tabs 12.5mg 28 and at the four shortages...
Sep 19, 2024
Charles Joynson, WaveData MD, has conducted some indepth analysis to try to identify early warning signs of generic shortages. Here’s the second instalment In the first instalment of this series, we looked at Losartan Tabs 12.5mg 28 and at the four shortages of...
